GE HealthCare Technologies Inc - Company Profile
Powered by 
All the sales intelligence you need on GE HealthCare Technologies Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how GE HealthCare Technologies Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with GE HealthCare Technologies Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
GE HealthCare Technologies Inc (GE HealthCare) is a medical technology, pharmaceutical diagnostics, and digital solutions company. It designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing, and cellular technologies; imaging agents used during medical scanning procedures; and healthcare IT solutions. GE HealthCare also provides services such as performance improvement and performance solutions services, computerized data management, and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE HealthCare is headquartered in Chicago, Illinois, the US.
Headquarters
United States of America
Address
500 West Monroe Street, Chicago, Illinois, 60661
Website
www.gehealthcare.com
Telephone
1 302 6587581
No of Employees
54,000
Industry
Medical Equipment
Ticker Symbol & Exchange
GEHC (NASD)
Revenue (2024)
$20.6B
4.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
4.6%
(2024 vs 2023)
Market Cap*
$28.6B
Net Profit Margin (2024)
XYZ
-0.3%
(2024 vs 2023)
* As of and is in US$
GE HealthCare Technologies Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Imaging: | Expert Services Delivery: | Definium |
| Bone and Metabolic Health | Service Contracts | Pixxoscan |
| Fluoroscopy | AssurePoint Refresh | Signa Magnus |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In July, the company announced its research collaboration with Mayo Clinic on MI-BET to develop a more personalized radioligand therapy approach for patients with advanced prostate cancer. |
| 2026 | Regulatory Approval | In June, the company secured 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtegeAI+ 2.0, an AI-enabled auto-contouring software. |
| 2026 | Product Recall | In June, the company recalled Giraffe and Panda Infant Resuscitation Systems and Warmers with an M1091607-R Blender to correct safety risks. |
Competitor Comparison
| Key Parameters | GE HealthCare Technologies Inc | Bayer AG | Siemens Healthineers AG | Shenzhen Mindray Bio-Medical Electronics Co Ltd | Bracco SpA |
|---|---|---|---|---|---|
| Headquarters | United States of America | Germany | Germany | China | Italy |
| City | Chicago | Leverkusen | Forchheim | Shenzhen | Milan |
| State/Province | Illinois | Nordrhein-Westfalen | Bayern | Guangdong | - |
| No. of Employees | 54,000 | 87,757 | 72,000 | 21,288 | 4,000 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| H. Lawrence Culp, Jr | Chairman | Executive Board | 2023 | 62 |
| Peter J. Arduini | Chief Executive Officer; President; Director | Executive Board | 2023 | 61 |
| James K. Saccaro | Vice President; Chief Financial Officer | Senior Management | 2023 | 53 |
| Ivan Martinez | Chief Strategy Officer | Senior Management | 2025 | - |
| Jahid Khandaker | Chief Information Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer